Prestige Consumer Healthcare In

Historical 13F Holders

Symbol
PBH
CUSIP
74112D101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74112D101 since 12/18/2024, newest first.

Filer % of Class Filed
Ariel Investments, LLC 13G/A Amendment 2 10.3% 7/7/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.2% 4/30/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 6.0% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 17 0% 3/27/2026
Event 3/13/2026
Ariel Investments, LLC 13G/A Amendment 1 8.5% 2/13/2026
Event 12/31/2025
Ariel Investments, LLC 13G 7.3% 11/14/2025
Event 9/30/2025
Ariel Investments, LLC 13G/A Amendment 1 4.5% 8/13/2025
Event 6/30/2025
BlackRock, Inc. 13G/A Amendment 15 15.2% 4/30/2025
Event 3/31/2025
Macquarie Group Ltd 13G/A Amendment 1
4.7% 2/7/2025
Event 12/31/2024
Dimensional Fund Advisors LP 13G/A Amendment 6 5.9% 1/23/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 8 175 k $8.02 M
2026 Q2 323 56.4 M $2.60 B
2026 Q1 358 52.0 M $3.08 B
2025 Q4 361 51.7 M $3.19 B
2025 Q3 362 51.3 M $3.20 B
2025 Q2 384 52.4 M $4.18 B
2025 Q1 367 51.8 M $4.45 B
2024 Q4 344 52.5 M $4.10 B
2024 Q3 332 51.4 M $3.70 B
2024 Q2 315 52.2 M $3.60 B
2024 Q1 327 53.9 M $3.91 B
2023 Q4 297 52.6 M $3.22 B
2023 Q3 287 51.0 M $2.91 B
2023 Q2 283 49.9 M $2.97 B
2023 Q1 293 50.8 M $3.16 B
2022 Q4 296 51.9 M $3.26 B
2022 Q3 285 50.1 M $2.50 B
2022 Q2 290 51.3 M $2.98 B
2022 Q1 290 51.0 M $2.71 B
2021 Q4 278 50.6 M $3.07 B
2021 Q3 249 50.8 M $2.85 B
2021 Q2 234 52.0 M $2.71 B
2021 Q1 249 52.6 M $2.32 B
2020 Q4 250 56.1 M $1.96 B
2020 Q3 247 53.4 M $1.94 B
2020 Q2 265 55.4 M $2.08 B
2020 Q1 258 54.6 M $2.00 B
2019 Q4 239 61.4 M $2.49 B
2019 Q3 237 60.8 M $2.11 B
2019 Q2 223 65.3 M $2.07 B
2019 Q1 228 65.1 M $1.95 B
2018 Q4 248 65.5 M $2.02 B
2018 Q3 252 66.9 M $2.53 B
2018 Q2 245 64.5 M $2.47 B
2018 Q1 248 65.4 M $2.21 B
2017 Q4 254 62.3 M $3.16 B
2017 Q3 242 58.2 M $2.92 B
2017 Q2 239 53.9 M $2.85 B
2017 Q1 247 52.9 M $2.94 B
2016 Q4 245 52.4 M $2.72 B
2016 Q3 253 52.3 M $2.52 B
2016 Q2 279 52.8 M $2.93 B
2016 Q1 265 53.5 M $2.86 B
2015 Q4 247 54.3 M $2.79 B
2015 Q3 217 55.2 M $2.50 B
2015 Q2 213 53.3 M $2.46 B
2015 Q1 199 54.0 M $2.31 B
2014 Q4 180 55.8 M $1.94 B
2014 Q3 182 55.4 M $1.79 B
2014 Q2 188 54.4 M $1.84 B
2014 Q1 175 52.2 M $1.42 B